<PAGE>
SECURITIES AND EXCHANGE COMMISSION
WASHINGTON, D.C. 20549
-------------------------------
FORM 8-K/A
CURRENT REPORT
PURSUANT TO SECTION 13 OR 15(d) OF THE
SECURITIES EXCHANGE ACT OF 1934
----------------------------------
DATE OF REPORT (DATE OF EARLIEST EVENT REPORTED): OCTOBER 16, 2000
-----------------
INVERNESS MEDICAL TECHNOLOGY, INC.
(EXACT NAME OF REGISTRANT AS SPECIFIED IN CHARTER)
DELAWARE 0-20871 04-3164127
---------------------------- ------------------------ -------------
(STATE OR OTHER JURISDICTION (COMMISSION FILE NUMBER) (IRS EMPLOYER
OF INCORPORATION) IDENTIFICATION NO.)
200 PROSPECT STREET, WALTHAM, MASSACHUSETTS 02453
-------------------------------------------------
(ADDRESS OF PRINCIPAL EXECUTIVE OFFICES) (ZIP CODE)
(781) 647-3900
--------------
(REGISTRANT'S TELEPHONE NUMBER, INCLUDING AREA CODE)
<PAGE>
ITEM 5. OTHER EVENTS
This Form 8-K/A is filed as an amendment to the Current Report on Form
8-K filed by Inverness Medical Technology, Inc., a Delaware corporation (the
"Company") on October 6, 2000 in connection with the announcement on October 4,
2000 that the Company signed an Agreement and Plan of Merger (the "Merger
Agreement") with Integ Incorporated, a Minnesota corporation ("Integ"), pursuant
to which the parties will effect a business combination through a merger of
Integ with and into Terrier Acquisition Corp., a Delaware corporation and
wholly-owned subsidiary of the Company (the "Merger"). As a result of the
Merger, Integ will become a wholly-owned subsidiary of the Company.
ITEM 7. FINANCIAL STATEMENTS, PRO FORMA FINANCIAL INFORMATION AND EXHIBITS
(c) EXHIBITS
99.1 First Amendment to Agreement and Plan of Merger, dated
as of October 16, 2000, by and among Inverness Medical
Technology, Inc., Terrier Acquisition Corp. and Integ
Incorporated.
99.2 Loan Agreement, dated as of October 3, 2000, by and
among Inverness Medical Technology, Inc. and Integ
Incorporated.*
* Incorporated by reference to the Current Report on Form 8-K,
dated October 3, 2000, filed by Integ Incorporated with
the Commission (File No. 0-28420).
2
<PAGE>
SIGNATURE
Pursuant to the requirements of the Securities Exchange Act of 1934, the
Registrant has duly caused this amended report to be filed on its behalf by the
undersigned thereunto duly authorized
INVERNESS MEDICAL TECHNOLOGY, INC.
Dated: October 18, 2000 By:/s/Duane L. James
-----------------------------------------
Name: Duane L. James
Title: Vice President of Finance
3
<PAGE>
EXHIBIT INDEX
Exhibit No. Description
----------- -----------
Exhibit 99.1 -- First Amendment to Agreement and Plan of Merger,
dated as of October 16, 2000, by and among
Inverness Medical Technology, Inc., Terrier
Acquisition Corp. and Integ Incorporated.
4
